Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Depressions, Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00441636
What this trial is testing

Treatment Resistant Depression and Obstructive Sleep Apnea, Effect of Continuous Positive Airway Pressure (CPAP)

Who this might be right for
DepressionSleep Apnea, Obstructive
Queen's University 120
Testing effectiveness (Phase 2)Study completedNCT04979910
What this trial is testing

Targeting IL-17A for Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder
Icahn School of Medicine at Mount Sinai 7
Not applicableNot Yet RecruitingNCT07824973
What this trial is testing

Ketamine Treatment for Treatment-Resistant Depression - the Role of Framing

Who this might be right for
Treatment Resistant Depression (TRD)
Valdemar Landgren 120
Large-scale testing (Phase 3)Looking for participantsNCT07623135
What this trial is testing

Lumateperone for Late-Life Depression

Who this might be right for
Treatment Resistant Depression (TRD)Late Life Depression (LLD)Depression / Major Depressive Disorder
Eric Lenze 100
Large-scale testing (Phase 3)Ended earlyNCT01687478
What this trial is testing

Olanzapine and Fluoxetine for Treatment-resistant Depression

Who this might be right for
Treatment Resistant Depression
Eli Lilly and Company 176
Testing effectiveness (Phase 2)Ended earlyNCT04141904
What this trial is testing

Tofacitinib in Depression (TIDE)

Who this might be right for
DepressionInflammation
University of Oxford 2
Not applicableEnrolling By InvitationNCT07737990
What this trial is testing

Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression

Who this might be right for
Treatment-resistant Depression (TRD)
Joshua Rosenblat 65
Not applicableStudy completedNCT06232291
What this trial is testing

Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression

Who this might be right for
Treatment-Resistant DepressionMajor Depressive Disorder
Medical University of Gdansk 3
Post-approval studies (Phase 4)Study completedNCT05045378
What this trial is testing

Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression

Who this might be right for
Treatment-resistant DepressionMajor Depressive Disorder
Taipei Veterans General Hospital, Taiwan 12
Early research (Phase 1)Ended earlyNCT02675556
What this trial is testing

Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression

Who this might be right for
Treatment Resistant Depression
Joshua M Hare 1
Not applicableStudy completedNCT00953745
What this trial is testing

Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder
Washington University School of Medicine 43
Not applicableStudy completedNCT01597167
What this trial is testing

Magnesium Sulfate Versus 5% Dextrose With Treatment Resistant Depression

Who this might be right for
Depression
University of Miami 21
Large-scale testing (Phase 3)Study completedNCT03113968
What this trial is testing

ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)

Who this might be right for
Treatment Resistant DepressionElectroconvulsive TherapyECT+6 more
Bo Hu 403
Post-approval studies (Phase 4)Study completedNCT03149991
What this trial is testing

Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)

Who this might be right for
Depression
Massachusetts General Hospital 51
Early research (Phase 1)Study completedNCT02577250
What this trial is testing

Ketamine Infusions for PTSD and Treatment-Resistant Depression

Who this might be right for
Depressive Disorder, Treatment-ResistantStress Disorders, Post-Traumatic
Minneapolis Veterans Affairs Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT04739865
What this trial is testing

The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression

Who this might be right for
Treatment Resistant Depression
COMPASS Pathways 19
Not applicableStudy completedNCT01515215
What this trial is testing

Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depressive Disorder

Who this might be right for
Major Depressive Disorder
Centre for Addiction and Mental Health 107
Large-scale testing (Phase 3)Study completedNCT04039022
What this trial is testing

Open-Label Safety Study of AXS-05 in Subjects With Depression

Who this might be right for
Major Depressive DisorderTreatment Resistant DepressionDepression
Axsome Therapeutics, Inc. 876
Post-approval studies (Phase 4)Looking for participantsNCT07080723
What this trial is testing

Algorithm Guided Treatment Versus Treatment as Usual (TAU) for Patients With Treatment Resistant Depression

Who this might be right for
Treatment Resistant Depression (TRD)
Aalborg University Hospital 80
Not applicableStudy completedNCT02974296
What this trial is testing

Neuroimaging in Patients Undergoing TMS for Depression

Who this might be right for
Treatment Resistant Depression
New York State Psychiatric Institute 33
Next Page